SPECIAL TOPIC
α,α-Disubstituted Nitrophosphonates
1657
HRMS (ESI): m/z calcd for C18H31NO7PS [M + H]+: 436.1533;
found: 436.1547.
References
(1) (a) Chavane, V. Bull. Soc. Chim. Fr. 1948, 15, 774.
Diethyl (R)-[3-Nitro-1-(phenylsulfonyl)dodecan-3-yl]phospho-
nate (3e)
(b) Kudzin, Z. H.; Kudzin, M. H.; Drabowicz, J.; Stevens, C.
V. Curr. Org. Chem. 2011, 15, 2015. (c) Orsini, F.; Sello,
G.; Sisti, M. Curr. Med. Chem. 2010, 17, 264. (d) Smith, A.
B. III; Yager, K. M.; Taylor, C. M. J. Am. Chem. Soc. 1995,
117, 10879.
Yield: 12.0 mg (98%); colorless oil.
HPLC analysis: Daicel Chiralpak IA, n-hexane–i-PrOH (90:10),
1.0 mL/min, λ = 254 nm, tR (major) = 9.7 min, tR (minor) = 11.9
min; 92% ee.
(2) For selected articles, see: (a) Allen, J. G.; Atherton, F. R.;
Hall, M. J.; Hassall, C. H.; Holmes, S. W.; Lambert, R. W.;
Nisbet, L. J.; Ringrose, P. S. Nature 1978, 272, 56.
(b) Atherton, F. R.; Hassall, C. H.; Lambert, R. W. J. Med.
Chem. 1986, 29, 29. (c) Pratt, R. F. Science 1989, 246, 917.
(d) Maier, L.; Diel, P. J. Phosphorus Sulfur Silicon 1991, 57,
57. (e) Kaplan, A. P.; Bartlett, P. A. Biochemistry 1991, 30,
8165. (f) Hirschmann, R.; Smith, A. B. III; Taylor, C. M.;
Benkovic, P. A.; Taylor, S. D.; Yager, K. M.; Sprengler, P.
A.; Benkovics, S. J. Science 1994, 265, 234. (g) Alonso, E.;
Solis, A.; del Pozo, C. Synlett 2000, 698. (h) Sienczyk, M.;
Oleksyszyn, J. Curr. Med. Chem. 2009, 16, 1673. (i) Mucha,
A.; Kafarski, P.; Berlicki, Ł. J. Med. Chem. 2011, 54, 5955.
(3) For selected examples, see: (a) Ma, J. Chem. Soc. Rev. 2006,
35, 630. (b) Merino, P.; Marques-Lopez, E.; Herrera, R. P.
Adv. Synth. Catal. 2008, 350, 1195. (c) Schlemminge, I.;
Saida, Y.; Groeger, H.; Maison, W.; Durot, N.; Sasai, H.;
Shibasaki, M.; Martens, J. J. Org. Chem. 2000, 65, 4818.
(d) Joly, G. D.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126,
4102. (e) Saito, B.; Egami, H.; Katsuki, T. J. Am. Chem. Soc.
2007, 129, 1978. (f) Kiyohara, H.; Nakamura, Y.;
1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 7.0 Hz, 3 H), 1.13–1.41
(m, 20 H), 1.99–2.02 (m, 1 H), 2.25–2.29 (m, 1 H), 2.38–2.43 (m, 1
H), 2.64–2.70 (m, 1 H), 3.40–3.41 (m, 2 H), 4.12–4.22 (m, 4 H),
7.58–7.61 (m, 2 H), 7.67–7.70 (m, 1 H), 7.92–7.93 (m, 2 H).
13C NMR (125 MHz, CDCl3): δ = 14.1, 16.3, 22.6, 23.1, 23.2, 26.5,
29.1, 29.3, 31.8, 35.7, 51.6, 64.2, 64.7, 64.8, 91.3, 92.5, 128.1,
129.4, 134.0, 138.6.
HRMS (ESI): m/z calcd for C22H39NO7PS [M + H]+: 492.2179;
found: 492.2183.
Diethyl (R)-[2-Nitro-1-phenyl-4-(phenylsulfonyl)butan-2-
yl]phosphonate (3f)
Yield: 6.3 mg (53%); colorless oil.
HPLC analysis: Daicel Chiralpak IA, n-hexane–i-PrOH (90:10),
1.0 mL/min, λ = 254 nm, tR (major) = 13.6 min, tR (minor) = 14.6
min; 92% ee.
1H NMR (500 MHz, CDCl3): δ = 1.30–1.34 (m, 6 H), 2.23–2.41 (m,
2 H), 3.16–3.20 (m, 1 H), 3.27–3.34 (m, 1 H), 3.50–3.56 (m, 1 H),
3.72–3.77 (m, 1 H), 4.17–4.27 (m, 4 H), 6.98–6.70 (m, 2 H), 7.23–
7.27 (m, 3 H), 7.47–7.50 (m, 2 H), 7.58–7.60 (m, 1 H), 7.78–7.80
(m, 2 H).
13C NMR (125 MHz, CDCl3): δ = 16.1, 26.7, 42.5, 51.5, 64.1, 65.0,
92.3, 92.5, 127.9, 128.1, 128.6, 129.1, 129.7, 131.7, 131.8, 133.7,
138.2.
HRMS (ESI): m/z calcd for C20H26NO7PS + Na [M + Na]+:
478.1060; found: 478.1057.
Matsubara, R.; Kobayashi, S. Angew. Chem. Int. Ed. 2006,
45, 1615. (g) Dodda, R.; Zhao, C.-G. Tetrahedron Lett.
2007, 48, 4339. (h) Bernardi, L.; Zhuang, W.; Jørgensen, A.
K. J. Am. Chem. Soc. 2005, 127, 5772. (i) Kim, M. S.; Hye,
R. K.; Kim, Y. D. Org. Lett. 2005, 7, 2309. (j) Kuwano, R.;
Nishio, R.; Ito, Y. Org. Lett. 1999, 1, 837. (k) Reddy, M. V.
N.; Balakrishna, A.; Kumar, M. A.; Reddy, G. C. S.; Sankar,
A. U. R.; Reddy, C. S.; Krishna, T. M. Chem. Pharm. Bull.
2009, 57, 1391.
Diethyl (S)-[4-Methyl-3-nitro-1-(phenylsulfonyl)pentan-3-
yl]phosphonate (3g)
Yield: 5.1 mg (50%); colorless oil.
(4) Wilt, J. C.; Pink, M.; Johnston, J. N. Chem. Commun. 2008,
4177.
(5) Bera, K.; Namboothiri, I. N. N. Org. Lett. 2012, 14, 980.
(6) Tripathi, C. B.; Kayal, S.; Mukherjee, S. Org. Lett. 2012, 14,
3296.
HPLC analysis: Daicel Chiralpak IA, n-hexane–i-PrOH (90:10),
1.0 mL/min, λ = 254 nm, tR (major) = 17.8 min, tR (minor) = 21.3
min; 92% ee.
(7) For reviews, see: (a) Nielsen, M.; Jacobsen, C. B.; Holub,
N.; Paixão, M. W.; Jørgensen, K. A. Angew. Chem. Int. Ed.
2010, 49, 2668. (b) Zhu, Q.; Lu, Y. Aust. J. Chem. 2009, 62,
951. For recent examples, see: (c) Li, H.; Song, J.; Liu, X.;
Deng, L. J. Am. Chem. Soc. 2005, 127, 8948. (d) Li, H.;
Song, J.; Deng, L. Tetrahedron 2009, 65, 3139. (e) Mossé,
S.; Alexakis, A. Org. Lett. 2005, 7, 4361. (f) Quintard, A.;
Bournaud, C.; Alexakis, A. Chem. Eur. J. 2008, 14, 7504.
(g) Quintard, A.; Alexakis, A. Chem. Eur. J. 2009, 15,
11109. (h) Sulzer-Mossé, S.; Alexakis, A.; Mareda, J.;
Bollot, G.; Bernardinelli, G.; Filinchuk, Y. Chem. Eur. J.
2009, 15, 3204. (i) Quintard, A.; Belot, S.; Sebastien, M.;
Marchal, E.; Alexakis, A. Eur. J. Org. Chem. 2010, 927.
(j) Quintard, A.; Alexakis, A. Chem. Commun. 2010, 46,
4085. (k) Landa, A.; Maestro, M.; Masdeu, C.; Puente, A.;
Vera, S.; Oiarbide, M.; Palomo, C. Chem. Eur. J. 2009, 15,
1562. (l) Liu, T.-Y.; Long, J.; Li, B.-J.; Jiang, L.; Li, R.; Wu,
Y.; Ding, L.-S.; Chen, Y.-C. Org. Biomol. Chem. 2006, 4,
2097. (m) Alba, A.-N. R.; Companyo, X.; Valero, G.;
Moyano, A.; Rios, R. Chem. Eur. J. 2010, 16, 5354.
(8) (a) Zhu, Q.; Lu, Y. Org. Lett. 2008, 10, 4803. (b) Zhu, Q.;
Cheng, L.; Lu, Y. Chem. Commun. 2008, 6315. (c) Zhu, Q.;
Lu, Y. Org. Lett. 2009, 11, 1721. (d) Zhu, Q.; Lu, Y. Chem.
Commun. 2010, 46, 2235. (e) Zhu, Q.; Lu, Y. Angew. Chem.
Int. Ed. 2010, 49, 7753.
1H NMR (500 MHz, CDCl3): δ = 0.86 (d, J = 7.0 Hz, 3 H), 1.11 (d,
J = 6.9 Hz, 3 H), 1.29–1.35 (m, 6 H), 1.78 (d, J = 14.5 Hz, 3 H),
2.28–2.35 (m, 1 H), 2.44–2.56 (m, 1 H), 2.82–2.90 (m, 1 H), 3.41–
3.54 (m, 2 H), 4.10–4.27 (m, 4 H), 7.58–7.61 (m, 2 H), 7.67–7.70
(m, 1 H), 7.93–7.95 (m, 2 H).
13C NMR (125 MHz, CDCl3): δ = 16.3, 17.2, 17.3, 18.2, 36.6, 51.8,
64.2, 64.4, 128.0, 129.4, 133.9.
HRMS (ESI): m/z calcd for C16H27NO7PS [M + H]+: 408.1240;
found: 408.1240.
Acknowledgment
We thank the National University of Singapore (R-143-000-469-
112) and the Ministry of Education (MOE) of Singapore (R-143-
000-494-112), and GSK-EDB (R-143-000-491-592) for generous
financial support.
Supporting Information for this article is available online at
n
nfomartit
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2013, 45, 1654–1658